Cancer Education Day Diagnostic Assessment Programs DAPs May 13, 2016.

Slides:



Advertisements
Similar presentations
Leading and innovating for excellence. Working towards the Best Cancer System in the World.
Advertisements

A Case Study GP Masterclass Catherine Dale, RN, BSc Cancer Care
Lung Cancer Presentation Dr Richard Sullivan and Ms Anne Fraser 6 th November 2014.
Spotlight on Colorectal Cancer Screening 1 1. Home Screening for Colon Cancer
J Thorac Dis 2013;5(S5) Estimated 10 year survival 88%, regardless of treatment Survival rate 92% if surgical resection in 1 month.
By Dr Varuna Paranahewa
Implementation of the Navigator Role in Community – Based Oncology Program Our Journey Joan M. Daugherty, RN, MS Executive Director, Richard A. Henson.
Carcinoma Lung.
School for Primary Care Research Increasing the evidence base for primary care practice The School for Primary Care Research is a partnership between the.
Matthew Kilmurry, M.D. St. Mary’s General Hospital Grand River Hospital.
Lung Cancer Wael Batobara. Lung Cancer Importance Risk Factors Classification & Manifestations Diagnosis Treatment.
In the name of God Fariba Rezaeetalab Assistant Professor.
Diagnosis and Management of TB John Yates Consultant Infectious Diseases.
TriLHIN ICS Orientation Workshop July 16, 2014 Dr. Jan Owen, MD, CCFP, FCFP Regional Primary Care Lead, SWRCP Screening Cancer.
DEVELOPMENT AND IMPLEMENTATION OF A LUNG NODULE PROGRAM Tamra Kelly, BS RRT-NPS, Gary B. Mertens, RCP, CPFT, Jenifer Beasley, RRT, Departments of Cancer.
Breast Cancer 101 Barbara Lee Bass, MD, FACS Professor of Surgery
 ,463 people  ,371 deaths  9/10 lung cancer >60 years  Only 5% adult lung cancer predicted to survive ≥10 years.
Mary S. McCabe Survivorship Care Planning. National Directions Focus on recurrence Increasing expectations by patients and families Identification of.
Acute Oncology Service (AOS) Monday – Friday 8am – 4pm Bleep: 946 T: x5726 F: Dr Nicola Beech Dr Jillian Noble Dr Susannah.
How to manage suspected cancer
Prostate Cancer By: Kurt Rishel.
Dr A.J.France. Ninewells Hospital, Dundee Lung Cancer 2010.
PRESENTING LUNG CANCER. Lung Cancer: Defined  Uncontrolled growth of malignant cells in one or both lungs and tracheo-bronchial tree  A result of repeated.
Detect Cancer Early. February 2012 The Scottish Government Announced
Department of General Practice Aarhus University Diagnostic delay in cancer in primary health care Before and after introducing urgent referrals for suspected.
Organized Diagnostic Assessment Demonstration Projects Organized Diagnostic Assessment Demonstration Projects Grand River Regional Diagnostic Assessment.
Tuberculosis Research of INA-RESPOND on Drug-resistant
Quality in Cancer Surgery Dr. Craig McFadyen VP Cancer Services, Grand River Hospital Regional VP (Waterloo-Wellington), Cancer Care Ontario Medical Director.
The Transition to What you need to know for Pulmonary Medicine Date | Presenter Information.
Idiopathic Pulmonary Fibrosis: Diagnosis and Understanding
Prostate Cancer Coalition of NC A statewide collaborative effort by concerned organizations and individuals to support awareness, early detection, and.
The KU Wichita Center for Breast Cancer Survivorship Judy Johnston, MS, RD/LD Research Instructor Department of Preventive Medicine and Public Health,
Component 1: Measures of Assessment and Monitoring n Two aspects: –Initial assessment and diagnosis of asthma –Periodic assessment and monitoring.
MARK COLEMAN MBChB FRCS (Gen Surg) MD hon FRCPSG Consultant Colorectal Surgeon
Organized Diagnostic Assessment Demonstration Projects Organized Diagnostic Assessment Demonstration Projects Streamlined Centre for Out-Patient Endoscopy.
Standard 2. Diagnosis The registered nurse analyzes the assessment data to determine the diagnosis or the issues.
Radiology “Dos and Don’ts” Clinical Governance Medical Division 18 July 2013.
Introduction to Tumor Board
Disease Pathway Management: Cancer Care Ontario’s Approach
Summary The National Clinical Pathway represents a pathway that is achievable now, requiring no extra resources but reliant on appropriate logistics. The.
Slides last updated: March NSCLC is most often diagnosed at an advanced stage Many of the symptoms that do appear with more advanced disease can.
LUNG CANCER DR HUDA BADRI. OVERVIEW OF SESSION Learning objectives Quiz Tutorial on lung cancer and guidelines 15 minutes break Case studies 10minutes.
Early Diagnosis of Gynaecological Cancer Rob Gornall Consultant Gynaecology GHNHST.
Macmillan Ipswich Diagnostic Assessment Service (MIDAS)
National Optimal Clinical Pathway for suspected and confirmed lung cancer: Referral to treatment Note: this was previously circulated for discussion as.
Implementation of a lung health clinic in high-risk individuals in South East London: a prospective feasibility cohort study Background In 2013, lung cancer.
National Clinical Pathway for suspected and confirmed lung cancer:
2016/17 Q1 Performance Scorecard - DRAFT
Instructor Kathleen Gamblin, RN, BSN, OCN Oncology Nurse Navigator
IT Solutions – Improving Timely Access to Health Care
Improving access through Innovation
‘Piloting change’ report on the Multi Disciplinary Diagnostic centre
Demystifying Cancer Genetics
2015/16 Q4 Performance Scorecard - DRAFT
Two Week Wait Referral Forms
BREAST CANCER ONCOLOGY NAVIGATION SERVICE
Coordination (benign lesions)
Cancer Prevention Screening and Early Detection PROF.MAZIN AL-HAWAZ.
Common cancers and NICE
Lung Cancer Screening:
Pre-session Number2 (Trial-2 /// 8July2013)
Dr James Carlton, Medical Adviser
Hiren J. Mehta, MD, Tan-Lucien Mohammed, MD, Michael A. Jantz, MD 
Barts Health Trust 2WW Colorectal Workshop Dr Angela Wong,
The BAHNO Head & Neck Cancer Surveillance Audit 2018
Lung Cancer Screening Sandra Starnes, MD Professor of Surgery
Survivorship: Living Beyond Lung Cancer
The BAHNO Head & Neck Cancer Surveillance Audit 2018
28 Day Faster Diagnosis Standard
Nursing care of patients operated-on for CRC
Presentation transcript:

Cancer Education Day Diagnostic Assessment Programs DAPs May 13, 2016

DAPs In the Per-Diagnostic period, patients can present with: – Abnormal screening results – OR – Signs or symptoms suspicious for cancer

Disclosures No Disclosure to report No conflict of interest

Abnormal Follow-up Rates for: Breast, Cervical and CRC Screening

Primary Care Factors Shown to Delay Cancer Diagnosis Not recognizing signs/symptoms suggestive of cancer Co-morbidity of conditions Multiple consecutive investigations in primary care Over-reliance on diagnostic imaging Imaging follow-up failure Initial referral to a physician unrelated to final diagnosis Patient Factors Shown to Delay Cancer Diagnosis Lack of appreciation of association of symptoms with cancer Fear of cancer diagnosis

What is the Problem We’re Trying to Solve? “This was really my first introduction to the cancer system and I saw very quickly how overwhelming it was to keep track of things when you’re not only feeling unwell, but are also under stress from the fear and anxiety of what’s going on. It would be very easy to get lost along the way.” – DAP Patient

What are Diagnostic Assessment Programs (DAPs)? WHAT IS A DAP? Diagnostic Assessment Programs (DAPs) are designed to improve the experience of patients with suspected cancer as they go through the diagnosis process. These programs are based in hospitals and are made up of multi-disciplinary healthcare teams that manage and coordinate a patient’s diagnostic care from testing to a definitive diagnosis, leading to improved access to care. DAPs also provide the necessary support and information about cancer to patients and their families THE DAP PROGRAM AT CCO HAS THREE OBJECTIVES: Decrease time from suspicion to diagnosis or resolution Improving patient outcomes where possible Optimize the patient experience during the diagnostic process Optimize satisfaction and experience among Primary Care Providers and Specialists DAP STATS: 17lung/thoracic, 14 colorectal, and 6 prostate DAPS across Ontario

How do Regional DAPs Function? DAPs are: Evidence-based programs based on CCO’s disease pathway maps and developed by Regional Cancer Programs across Ontario Made up of multidisciplinary health care teams that manage and coordinate a patient’s diagnostic care from testing to a definitive diagnosis or rule-out of cancer

Erie St Clair (ESC) DAPs LungColorectalProstate Nurse Navigators – Julie Meloche and Melissa Capogna

ESC DAPs Nurse Navigators – Julie Meloche and Melissa Capogna

Suspicious Lung Cancer Signs and Symptoms in Primary Care Hemoptysis New finger clubbing Suspicious lymphadenopathy Dysphagia Features suggestive of cancer metastasis to or from the lung Features suggestive of paraneoplastic syndromes OR

Suspicious Lung Cancer Signs and Symptoms in Primary Care Any of following unexplained signs or symptoms lasting more than three weeks (patients with known risk factors may be considered sooner): Cough Weight loss/loss of appetite Shortness of breath Chest and/or shoulder pain Abnormal chest signs (e.g. crackles or wheezes) Hoarseness

Indications for Referral – Lung Persistent hemoptysis A chest X-ray suggestive/suspicious lung cancer including: A nodule or mass Multiple pulmonary nodules Non-resolving pleural effusion Mediastinal or contralateral hilar adenopathy Interstitial infiltrates Slowly or non-resolving pneumonia or consolidation Fibroapical disease suggesting possible tuberculosis Unexplained elevated diaphragm A normal chest X-ray, but there is a high suspicion of lung cancer, based on clinical judgement

Indications for Referral – Colorectal Positive FOBT result First Degree Family History (Mother, Father, Sibling, Child)

Indications for Referral – Prostate Currently work with 5 Urologists offices Referral into the program usually happens with a positive Digital Rectal Exam and 3 increasing PSA results – Biopsy is scheduled followed by a post biopsy to the patient to see how they’re doing – Biopsy pathology review by the DAP Nurse – Office is called when there is a positive pathology, and the date the patient will be told of their diagnosis confirmed – Patient is then given their surgical options – The DAP office coordinates any required bone scan, CT scan, etc. – These appointments are provided to the patient by the DAP nurse – A consultation appointment is then scheduled with a Radiation Oncologist at the Cancer Centre – The DAP nurse attends that appointment along with the patient to review the options

DAP –Wait Time Reporting There are Wait Times associated with the DAP program  Lung: 65% must be diagnosed within 28 days  Colorectal 1: – FOBT Positive must be seen within 8 weeks – Family History must be seen within 26 weeks This data is currently reported to Cancer Care Ontario every month

High Risk Lung Cancer Screening (HRLCS) CCO - Status Screening pathway Eligibility criteria Pilot site selection criteria Evaluation committee Evaluation criteria for pilots RFP Issued end of March Next Step-selection of pilot sites

HRLCS Pilot Site Requirements 1.Smoking cessation will be embedded 2.Navigator will assess eligibility 3.Navigator will be smoking cessation counsellor 4.Nodule management algorithm (LungRADS) 5.Seamless link with DAP 6.Recruitment of hard to reach high risk populations

Subset of pilot minimum requirements* Hospital stand-alone or hub and spoke models Primary care and community led recruitment PCP roster for unattached patients Screening navigator support On-site smoking cessation Standardized reporting template for LDCT On-site lung DAP On-site thoracic level 1 centre CCO led joint planning, recruitment, evaluation and ongoing performance management